Evidence map›Paper›PMID 40638909›Full record

Observational studyJournal of medical Internet research2025

AI Predictive Model of Mortality and Intensive Care Unit Admission in the COVID-19 Pandemic: Retrospective Population Cohort Study of 12,000 Patients.

Jose Manuel Ruiz Giardin, Óscar Garnica, Nieves Mesa Plaza, Juan Víctor SanMartín López, Ana Farfán Sedano, Elena Madroñal Cerezo, Miguel Ángel Duarte Millán, Aida Izquierdo Martínez, Luis Rivas, Marta Rivilla and 36 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Jose Manuel Ruiz Giardin *Medicina Interna-Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0001-9459-7386
Óscar Garnica *Departamento de Arquitectura de Computadores, Universidad Complutense de Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0001-5064-2587
Nieves Mesa PlazaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-1915-6673
Juan Víctor SanMartín LópezMedicina Interna-Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-4457-5124
Ana Farfán SedanoMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-4045-239X
Elena Madroñal CerezoMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-0189-3480
Miguel Ángel Duarte MillánMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-6138-7558
Aida Izquierdo MartínezMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0005-5693-1562
Luis RivasMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-0200-0883
Marta RivillaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0006-3624-261X
Alejandro Morales OrtegaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-8110-4498
Begoña Frutos PérezMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-4486-8365
Cristina De Ancos AracilMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-3832-8170
Ruth CalderónMedicina Interna-Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0002-2527-8781
Guillermo Soria FernandezMedicina Interna-Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0002-9069-9777
Jorge Marrero FrancésMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0005-0002-8825
David Bernal BelloMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-6887-1676
Jose Ángel Satué BartoloméMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-0697-3519
María Toledano MacíasMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0001-5349-1761
Sara Piedrabuena GarcíaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0001-0443-1903
Marta Guerrero SantillánMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0001-0999-1731
Rafael CristóbalMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-8980-5264
Belen MoraMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-0459-9562
Laura Velázquez RíosMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0007-8139-2139
Vanesa García de ViedmaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0005-4693-8947
Paula Cuenca RuizMedicina Interna-Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0007-7236-2245
Ibone Ayala LarrañagaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-9404-2177
Lorena CarpinteroMedicina Interna-Infecciosas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0003-9037-6086
Celia LaraMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-5311-156X
Alvaro Ricardo LlerenaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0009-2897-6279
Virginia García BermúdezMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-8197-2789
Gema Delgado CárdenasUrgencias, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0004-3880-0174
Paloma Pardo RoviraUrgencias, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0002-2870-0298
Elena Tejero SánchezUrgencias, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-3871-0361
Maria Jesús Domínguez GarcíaUrgencias, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0007-8749-3758
Carolina MariñoFarmacia Hospitalaria, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-3724-4629
Cristina BravoFarmacia Hospitalaria, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0005-8953-3800
Ana OntañonFarmacia Hospitalaria, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-8022-4244
Mario GarcíaFarmacia Hospitalaria, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0003-4385-6853
Jose Ignacio Hidalgo PérezDepartamento de Arquitectura de Computadores, Universidad Complutense de Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0002-3046-6368
Santiago Prieto MencheroLaboratorio Clínico, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0009-0007-5260-3355
Natalia González PereiraLaboratorio Clínico, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-7606-0339
Sonia Gonzalo PascuaMedicina Interna, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0002-9783-927X
Jorge Tarancón ReySistemas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-2341-8074
Luis Antonio Lechuga SuárezSistemas, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.ORCID https://orcid.org/0000-0003-3910-0861
FUENCOVID *Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the main challenges with COVID-19 has been that although there are known factors associated with a worse prognosis, clinicians have been unable to predict which patients, with similar risk factors, will die or require intensive care unit (ICU) care.

objectiveThis study aimed to develop a personalized artificial intelligence model to predict the patient risk of mortality and ICU admission related to SARS-CoV-2 infection during the initial medical evaluation before any kind of treatment.

methodsIt is a population-based, observational, retrospective study covering from February 1, 2020, to January 24, 2023, with different circulating SARS-CoV-2 viruses, vaccinated status, and reinfections. It includes patients attended by the reference hospital in Fuenlabrada (Madrid, Spain). The models used the random forest technique, Shapley Additive Explanations method, and processing with Python (version 3.10.0; Python Software Foundation) and scikit-learn (version 1.3.0). The models were applied to different epidemic SARS-CoV-2 infection waves. Data were collected from 11,975 patients (4998 hospitalized and 6737 discharged). Predictive models were built with records from 4758 patients and validated with 6977 patients after evaluation in the emergency department. Variables recorded were age, sex, place of birth, clinical data, laboratory results, vaccination status, and radiologic data at admission.

resultsThe best mortality predictor achieved an area under the receiver operating characteristic curve (AUC) of 0.92, sensitivity of 0.89, specificity of 0.82, positive predictive value (PPV) of 0.35, and mean negative predictive value (NPV) of 0.98. The ICU admission predictor had an AUC of 0.89, sensitivity of 0.75, specificity of 0.88, PPV of 0.37, and NPV of 0.98. During validation, the mortality model exhibited good performance for the nonhospitalized group, achieving an AUC of 0.95, sensitivity of 0.88, specificity of 0.98, PPV of 0.21, and NPV of 0.99, predicting the death of 30 of 34 patients who were not hospitalized. For the hospitalized patients, the mortality model achieved an AUC of 0.85, sensitivity of 0.86, specificity of 0.74, PPV of 0.24, and NPV of 0.98. The model for predicting ICU admission had an AUC of 0.82, sensitivity of 1.00, specificity of 0.59, PPV of 0.05, and NPV of 1.00. The models' metrics presented stability along all pandemic waves. Key mortality predictors included age, Charlson value, and tachypnea. The worse prognosis was linked to high values in urea, erythrocyte distribution width, oxygen demand, creatinine, procalcitonin, lactate dehydrogenase, heart failure, D-dimer, oncological and hematological diseases, neutrophil, and heart rate. A better prognosis was linked to higher values of lymphocytes and systolic and diastolic blood pressures. Partial or no vaccination provided less protection than full vaccination.

conclusionsThe artificial intelligence models demonstrated stability across pandemic waves, indicating their potential to assist in personal health services during the 3-year pandemic, particularly in early preventive and predictive clinical situations.

Indexed as

Artificial IntelligenceCOVID-19Intensive Care UnitsPatient AdmissionAdultAgedFemaleHospitalizationHumansMaleMiddle AgedPandemicsPrognosisRetrospective StudiesSARS-CoV-2Spainartificial intelligenceCOVID-19deathintensive care unitmortalitypopulation studypredictive modelrandom forestSARS-CoV-2

Identifiers

PMID40638909
PMCPMC12290426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.